P. Ponikowski

Publications752
h-index97
Citations44,932
Highly Influential Citations1,625
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • A. Voors
  • 791 Publications, 39,461 Citations
  • M. Metra
  • 755 Publications, 24,587 Citations
  • C. O'Connor
  • 1,128 Publications, 61,756 Citations
  • S. Anker
  • 684 Publications, 54,363 Citations
  • Publications
  • Influence
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European…
ABCD : Appropriate Blood pressure Control in Diabetes ABI : ankle–brachial index ABPM : ambulatory blood pressure monitoring ACCESS : Acute Candesartan Cilexetil Therapy in Stroke Survival ACCOMPLISH… Expand
  • 4,614
  • 240
  • PDF
[2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].
Authors/Task Force Members: Piotr Ponikowski* (Chairperson) (Poland), Adriaan A. Voors* (Co-Chairperson) (The Netherlands), Stefan D. Anker (Germany), Héctor Bueno (Spain), John G. F. Cleland (UK),… Expand
  • 5,215
  • 209
  • PDF
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.
AIMS The objective of the EuroHeart Failure Survey II (EHFS II) was to assess patient characteristics, aetiology, treatment, and outcome of acute heart failure (AHF) in Europe in relation to the… Expand
  • 986
  • 58
  • PDF
Ferric carboxymaltose in patients with heart failure and iron deficiency.
BACKGROUND Iron deficiency may impair aerobic performance. This study aimed to determine whether treatment with intravenous iron (ferric carboxymaltose) would improve symptoms in patients who had… Expand
  • 1,208
  • 46
  • PDF
Wasting as independent risk factor for mortality in chronic heart failure
BACKGROUND Wasting in chronic heart failure (CHF) has long been known but is little investigated. We sought to find out whether the cachectic state in CHF provides additional prognostic information… Expand
  • 1,186
  • 42
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
BACKGROUND In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through glucose-independent… Expand
  • 645
  • 38
ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE 2008 (ENDING)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (ending).
  • 983
  • 35
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.
BACKGROUND The role of hormonal and cytokine abnormalities in the development of cardiac cachexia remains obscure. METHODS AND RESULTS Healthy control subjects (n=16) and patients with chronic… Expand
  • 753
  • 28
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
OBJECTIVES Our purpose was to assess the diagnostic utility of mid-regional pro-atrial natriuretic peptide (MR-proANP) for the diagnosis of acute heart failure (AHF) and the prognostic value of… Expand
  • 428
  • 24
Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation
The European Society of Cardiology heart failure guidelines firmly recommend regular physical activity and structured exercise training (ET), but this recommendation is still poorly implemented in… Expand
  • 463
  • 24
  • PDF